Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana-Maria Gheorghiu

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|November 11, 2022
Arrhythmias and Conduction Disturbances in Patients with Systemic Sclerosis-A Systematic Literature ReviewCristina Andreea Vrancianu, Ana Maria Gheorghiu, Dragos Emanuel Popa, et al.
Rheumatology (Oxford, England)|December 3, 2019
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortCarina Mihai, Oliver Distler, Ana Maria Gheorghiu, et al.
Clinical Rheumatology|November 19, 2017
Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocolAlina Soare, Ana Maria Gheorghiu, Victoria Aramă, et al.
Journal of Scleroderma and Related Disorders|March 24, 2025
Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysisGonçalo Boleto, Corrado Campochiaro, Oliver Distler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 2018
Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic ArthritisAlina Soare, Stefanie Weber, Lisa Maul, et al.
Chest|June 7, 2024
Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic SclerosisAmalia Colalillo, Eric Hachulla, Chiara Pellicano, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2026
Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR databaseCorrado Campochiaro, Marie-Elise Truchetet, Madelon Vonk, et al.
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research DatabaseGemma Lepri, Cosimo Bruni, Lorenzo Tofani, et al.
The European Respiratory Journal|September 4, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|November 11, 2022
Arrhythmias and Conduction Disturbances in Patients with Systemic Sclerosis-A Systematic Literature ReviewCristina Andreea Vrancianu, Ana Maria Gheorghiu, Dragos Emanuel Popa, et al.
Rheumatology (Oxford, England)|December 3, 2019
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortCarina Mihai, Oliver Distler, Ana Maria Gheorghiu, et al.
Clinical Rheumatology|November 19, 2017
Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocolAlina Soare, Ana Maria Gheorghiu, Victoria Aramă, et al.
Journal of Scleroderma and Related Disorders|March 24, 2025
Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysisGonçalo Boleto, Corrado Campochiaro, Oliver Distler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 2018
Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic ArthritisAlina Soare, Stefanie Weber, Lisa Maul, et al.
Chest|June 7, 2024
Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic SclerosisAmalia Colalillo, Eric Hachulla, Chiara Pellicano, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2026
Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR databaseCorrado Campochiaro, Marie-Elise Truchetet, Madelon Vonk, et al.
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research DatabaseGemma Lepri, Cosimo Bruni, Lorenzo Tofani, et al.
The European Respiratory Journal|September 4, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Pageof 3